- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by LUN WEI LIU
Total 368 results
-
Wen Liu, Ph.D.American Heart AssociationTerminated
-
Jun LiuUnknownUlcerative Colitis | Fecal Microbiota Transplantation
-
Liu WeifengUnknown
-
Tao LinNot yet recruitingKidney TransplantationChina
-
Zongxun LinRecruiting
-
Lin ZhaoRecruitingIn-stent Restenosis | Major Adverse Cardiovascular EventsChina
-
Lin ZhaoRecruitingChronic Total Occlusion | Image | RevascularizationChina
-
Genglong LiuRecruitingExtracorporeal Membrane Oxygenation Complication | AMI - Acute Mesenteric IschemiaChina
-
Liu ZiMengUnknownSeptic Shock | TerlipressinChina
-
Zhen-Hai LuRecruitingAdvanced Rectal CancerChina
-
Shen LinNeoCuraNot yet recruitingGastric CancerChina
-
Song LinUnknownGlioblastoma MultiformeChina
-
Wei LiuAstraZeneca; University of Washington; Beijing Clinstech-med consulting Co., LtdUnknownCarotid AtherosclerosisChina
-
Zongxun LinRecruiting
-
Kaiyang LinCompleted
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchTerminated
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchTerminatedTranscranial Magnetic Stimulation | Depressive Disorder, MajorTaiwan
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingSomatoform Disorders | Somatic Symptom DisorderTaiwan
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingAdvanced Hepatocellular CarcinomaTaiwan
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchCompletedPanic Disorder | Feedback, PsychologicalTaiwan
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchUnknown
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchUnknownNon-small Cell Lung CancerTaiwan
-
Wen LuoCompletedImplant | Thin-gingiva | Clinical and Radiographic Effect | Thick-gingivaChina
-
Wen LuoCompletedThin Gingiva | Implant | Clinical and Radiographic Effect | Thick-gingivaChina
-
Hui-Ling LinRecruiting
-
Yu-Shiuan LinRecruiting
-
Lin ChenCompleted
-
Hui LinUnknownLung Adenocarcinoma Patients With Postoperative in pN2China
-
Kai Lin Xu; Jun Nian ZhengiCarTAB BioMed Inc.UnknownRecurrent or Refractory B Cell MalignancyChina
-
Lin ChenCompletedCritical Illness | Aspergillosis, Invasive Pulmonary | Exhaled Breath Condensate | Bronchoalveolar Lavage Fluid | Respiration Failure | Sensitivity and Specificity | Respiratory Fungal InfectionChina
-
Lin ChenUnknownGastric AdenocarcinomaChina
-
Lin ChenRecruitingEfficacy | Safety | HER2 Negative | Locally Advanced Gastric CarcinomaChina
-
Lin ChenCompletedSepsis | Cytokine Storm | Sympathetic Nervous System Diseases | Catecholamine; Overproduction | Immunologic Paralysis | Lymphocyte Disorder T | Beta-BlockerChina
-
Lin ChenCompletedImmunotherapy | Advanced Gastric CarcinomaChina
-
Lan LiRecruiting
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA IndexChina
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina
-
Lei LiRecruitingRecurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility OutcomesChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingEndometrial Neoplasms | SurvivalChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Lei LiUnknownCervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic AccuracyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNAChina
-
Lei LiUnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasChemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 AntibodyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
Lei LiUnknownEndometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial TissueChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | TumorigenesisChina